Expression of the PXR gene in various types of cancer and drug resistance (Review)

Oncology Letters

Volumn 5, Issue 4, 2013, Pages 1093-1100

  Qiao, Enqi ^a   Ji, Minghua ^a   Wu, Jianzhong ^a   Ma, Rong ^a   Zhang, Xiaohua ^b   He, Yuejun ^c   Zha, Quanbin ^c   Song, Xue ^a   Zhu, Li Wei ^a   Tang, Jinhai ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Multidrug resistance; Pregnane X receptor; Tumor cell apoptosis

Indexed keywords

CELL NUCLEUS RECEPTOR; CISPLATIN; CYTOCHROME P450 3A4; DOCETAXEL; DOXORUBICIN; ESTROGEN RECEPTOR; ETOPOSIDE; FARNOQUINONE; FIBROBLAST GROWTH FACTOR 19; FIRTECAN; FLUTAMIDE; GLUCURONOSYLTRANSFERASE; HYDROXYSTEROID SULFOTRANSFERASE; IFOSFAMIDE; IRINOTECAN; KETOCONAZOLE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 3; PACLITAXEL; PREGNANE X RECEPTOR; PROTEIN P53; RETINOIC ACID; RIFAMPICIN; TAMOXIFEN; VINBLASTINE; VINCRISTINE;

APOPTOSIS; BREAST CANCER; COLON ADENOCARCINOMA; COLON CANCER; COLORECTAL CANCER; CORRELATION ANALYSIS; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; GENE; GENE EXPRESSION; GENE FUNCTION; GENE STRUCTURE; HUMAN; LIVER CANCER; MULTIDRUG RESISTANCE; NEOPLASM; NONHUMAN; OSTEOSARCOMA; OVARY CARCINOMA; PREGNANE X RECEPTOR GENE; PROMYELOCYTIC LEUKEMIA; PROSTATE CANCER; RECEPTOR DOWN REGULATION; REVIEW; TUMOR CELL;

EID: 84874423034     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1149     Document Type: Review

References (84)

1. Lehmann JM, McKee DD, Watson MA, et al: The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102: 1016-1023, 1998.
2. Bertilsson G, Heidrich J, Svensson K, et al: Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci USA 95: 12208-12213, 1998.
3. Kliewer SA, Moore JT, Wade L, et al: An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92: 73-82, 1998.
4. Blumberg B, Sabbagh W Jr, Juguilon H, et al: SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev 12: 3195-3205, 1998.
5. Kast HR, Goodwin B, Tarr PT, et al: Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277: 2908-2915, 2002.
6. Geick A, Eichelbaum M and Burk O: Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 276: 14581-14587, 2001.
7. Goodwin B, Hodgson E and Liddle C: The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol 56: 1329-1339, 1999.
8. Kawana K, Ikuta T, Kobayashi Y, Gotoh O, Takeda K and Kawajiri K: Molecular mechanism of nuclear translocation of an orphan nuclear receptor, SXR. Mol Pharmacol 63: 524-531, 2003.
9. Zhang J, Kuehl P, Green ED, Touchman JW, et al: The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics 11: 555-572, 2001.
10. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H and Moras D: Crystal structure of the RAR-gamma Ligand-binding domain bound to all-trans retinoic acid. Nature 378: 681-689, 1995.
11. Xu HE, Stanley TB, Montana VG, et al: Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 415: 813-817, 2002.
12. Nolte RT, Wisely GB, Westin S, et al: Ligand binding and co-activator assembly of the peroxisome proliferator-activated Receptor-gamma. Nature 395: 137-143, 1998.
13. Watkins RE, Maglich JM, Moore LB, et al: 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry 42: 1430-1438, 2003.
14. Rosenfeld JM, Vargas R Jr, Xie W and Evans RM: Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol Endocrinol 17: 1268-1282, 2003.
15. Guengerich FP: Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 39: 1-17, 1999.
16. Wrighton SA, Schuetz EG, T hummel K E, Shen DD, Korzekwa KR and Watkins PB: The human CYP3A subfamily: practical considerations. Drug Metab Rev 32: 339-361, 2000.
17. Moore LB, Parks DJ, Jones SA, et al: Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275: 15122-15127, 2000.
18. Runge-Morris M, Wu W and Kocarek TA: Regulation of rat hepatic hydroxysteroid sulfotransferase (SULT2-40/41) gene expression by glucocorticoids: evidence for a dual mechanism of transcriptional control. Mol Pharmacol 56: 1198-1206, 1999.
19. Xie W, Yeuh MF, Radominska-Pandya A, et al: Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci USA 100: 4150-4155, 2003.
20. Chen C, Staudinger J L and Klaassen CD: Nuclear receptor, pregname X receptor, is required for induction of UDP-glucuronosyltranferases in mouse liver by pregnenolone-16 alpha-carbonitrile. Drug Metab Dispos 31: 908-915, 2003.
21. Yueh MF, Huang YH, Hiller A, Chen S, Nguyen N and Tukey RH: Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1. J Biol Chem 278: 15001-15006, 2003.
22. Shelby M K and Klaassen C D: Induction of rat UDP-glucuronosyltransferases in liver and duodenum by microsomal enzyme inducers that activate various transcriptional pathways. Drug Metab Dispos 34: 1772-1778, 2006.
23. Vyhlidal CA, Rogan PK and Leeder JS: Development and refinement of pregnane X receptor (PXR) DNA binding site model using information theory: insights into PXR-mediated gene regulation. J Biol Chem 279: 46779-46786, 2004.
24. Buckley DB and Klaassen CD: Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab Dispos 37: 847-856, 2009.
25. Synold TW, Dussault I and Forman BM: The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 7: 584-590, 2001.
26. Kast HR, Goodwin B, Tarr PT, et al: Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277: 2908-2915, 2002.
27. Jones SA, Moore LB, Shenk JL, et al: The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol 14: 27-39, 2000.
28. Wentworth JM, Agostini M, Love J, Schwabe JW and Chatterjee VK: St John's wort, a herbal antidepressant, activates the steroid X receptor. J Endocrinol 166: R11-R16, 2000.
29. Savas U, Wester MR, Griffin KJ and Johnson EF: Rabbit pregnane X receptor is activated by rifampicin. Drug Metab Dispos 28: 529-537, 2000.
30. Zhang H, LeCulyse E, Liu L, Hu M, Matoney L, Zhu W and Yan B: Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation. Arch Biochem Biophys 368: 14-22, 1999.
31. Cheng X and Klaassen CD: Regulation of mRNA expression of xenobiotic transporters by the pregnane X receptor in mouse liver, kidney, and intestine. Drug Metab Dispos 34: 1863-1867, 2006.
32. Bauer B, Hartz AM, Fricker G and Miller DS: Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol 66: 413-419, 2004.
33. Chirulli V, Longo V, Marini S, Mazzaccaro A, Fiorio R and Gervasi PG: CAR and PXR expression and inducibility of CYP2B and CYP3A activities in rat and rabbit lungs. Life Sci 76: 2535-2546, 2005.
34. Staudinger JL, Goodwin B, Jones SA, et al: The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 98: 3369-3374, 2001.
35. Masuyama H, Hiramatsu Y, Mizutani Y, Inoshita H and Kudo T: The expression of pregnane X receptor and its target gene, cytochrome P450 3A1, in perinatal mouse. Mol Cell Endocrinol 172: 47-56, 2001.
36. Dubrac S, Elentner A, Ebner S, Horejs-Hoeck J and Schmuth M: Modulation of T lymphocyte function by the pregnane X receptor. J Immunol 184: 2949-2957, 2010.
37. Owen A, Chandler B, Back DJ and Khoo SH: Expression of pregnane-X-receptor transcript in peripheral blood mononuclear cells and correlation with MDR1 mRNA. Antivir Ther 9: 819-821, 2004.
38. Albermann N, Schmitz-Winnenthal F H, Z'graggen K, et al: Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochem Pharmacol 70: 949-958, 2005.
39. Lamba V, Yasuda K, Lamba JK, Assem M, Davila J, Strom S and Schuetz EG: PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicol Appl Pharmacol 199: 251-265, 2004.
40. Dotzlaw H, Leygue E, Watson P and Murphy LC: The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin Cancer Res 5: 2103-2107, 1999.
41. Miki Y, Suzuki T, Kitada K, et al: Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma. Cancer Res 66: 535-542, 2006.
42. Mensah-Osman EJ, Thomas DG, Tabb MM, et al: Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines. Cancer 109: 957-965, 2007.
43. Zhou J, Liu M, Zhai Y and Xie W: The antiapoptotic role of pregnane X receptor in human colon cancer cells. Mol Endocrinol 22: 868-880, 2008.
44. Masuyama H, Hiramatsu Y, Kodama J and Kudo T: Expression and potential roles of pregnane X receptor in endometrial cancer. J Clin Endocrinol Metab 88: 4446-4454, 2003.
45. Masuyama H, Nakatsukasa H, Takamoto N and Hiramatsu Y: Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells. Mol Pharmacol 72: 1045-1053, 2007.
46. Gupta D, Venkatesh M, Wang H, et al: Expanding the roles for pregnane X receptor in cancer: proliferation and drug resistance in ovarian cancer. Clin Cancer Res 14: 5332-5340, 2008.
47. Chen Y, Tang Y, Wang MT, Zeng S and Nie D: Human pregnane X receptor and resistance to chemotherapy in prostate cancer. Cancer Res 67: 10361-10367, 2007.
48. Takeyama D, Miki Y, Fujishima F, Suzuki T, Akahira J, Hata S, Miyata G, Satomi S and Sasano H: Steroid and xenobiotic eceptor in human esophageal squamous cell carcinoma: a potent prognostic factor. Cancer Sci 101: 543-549, 2010.
49. Pfrunder A, Gutmann H, Beglinger C and Drewe J: Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. J Pharm Pharmacol 55: 59-66, 2003.
50. Jiang H, Chen K, He J, Pan F, Li J, Chen J, Chen W and Liang H: Association of pregnane X receptor with multidrug resistance-related protein 3 and its role in human colon cancer chemoresistance. J Gastrointest Surg 13: 1831-1838, 2009.
51. Harmsen S, Meijerman I, Febus CL, Maas-Bakker RF, Beijnen JH and Schellens JH: PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adeno carcinoma-derived cell line. Cancer Chemother Pharmacol 66: 765-771, 2010.
52. Habano W, Gamo T, Terashima J, Sugai T, Otsuka K, Wakabayashi G and Ozawa S: Involvement of promoter methylation in the regulation of pregnane X receptor in colon cancer cells. BMC Cancer 11: 81, 2011.
53. Raynal C, Pascussi JM, Leguelinel G, et al: Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation. Mol Cancer 9: 46, 2010.
54. Basseville A, Preisser L, de Carné Trécesson S, Boisdron-Celle M, Gamelin E, Coqueret O and Morel A: Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells. Mol Cancer 10: 80, 2011.
55. Zheng XE, Wang Z, Liao MZ, Lin YS, Shuhart MC, Schuetz EG and Thummel KE: Human PXR-mediated induction of intestinal CYP3A4 attenuates 1α,25-dihydroxyvitamin D3 function in human colon adenocarcinoma LS180 cells. Biochem Pharmacol 84: 391-401, 2012.
56. Wang H, Venkatesh M, Li H, et al: Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice. J Clin Invest 121: 3220-3232, 2011.
57. Khan F, Amatya B, Ng L, Demetrios M, Zhang NY and Turner-Stokes L: Multidisciplinary rehabilitation for follow-up of women treated for breast cancer. Cochrane Database Syst Rev 12: CD009553, 2012.
58. Conde I, Lobo MV, Zamora J, Pérez J, González FJ, Alba E, Fraile B, Paniagua R and Arenas MI: Human pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alpha. BMC Cancer 8: 174, 2008.
59. Meyer zu Schwabedissen HE, Tirona RG, Yip CS, Ho RH and im RB: Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Cancer Res 68: 9338-9347, 2008.
60. Sandanaraj E, Lal S, Selvarajan V, Ooi LL, Wong ZW, Wong NS, Ang PC, Lee EJ and Chowbay B: PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients. Clin Cancer Res 14: 7116-7126, 2008.
61. Choi HK, Yang JW, Roh SH, Han CY and Kang KW: Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells. Endocr Relat Cancer 14: 293-303, 2007.
62. Chen Y, Tang Y, Chen S and Nie D: Regulation of drug resistance by human pregnane X receptor in breast cancer. Cancer Biol Ther 8: 1265-1272, 2009.
63. Masuyama H, Suwaki N, Tateishi Y, Nakatsukasa H, Segawa T and Hiramatsu Y: The pregnane X receptor regulates gene expression in a ligand-and promoter-selective fashion. Mol Endocrinol 19: 1170-1180, 2005.
64. Takami N, Sakamoto H and Yamamoto T: Steroid and xenobiotic receptor (SXR) is a key system for the acquisition of cisplatin resistance in endometrial cancer cells. J Int Med Res 31: 59-68, 2003.
65. Yue X, Akahira J, Utsunomiya H, et al: Steroid and Xenobiotic Receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer. Pathol Int 60: 400-406, 2010.
66. Zhang B, Cheng Q, Ou Z, et al: Pregnane X receptor as a therapeutic target to inhibit androgen activity. Endocrinology 151: 5721-5729, 2010.
67. Fujimura T, Takahashi S, Urano T, et al: Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in uman prostate cancer. Cancer Sci 103: 176-180, 2012.
68. Maruyama M, Matsunaga T, Harada E and Ohmori S: Comparison of basal gene expression and induction of CYP3As in HepG2 and human fetal liver cells. Biol Pharm Bull 30: 2091-2097, 2007.
69. Azuma K, Urano T, Ouchi Y and Inoue S: Vitamin K2 suppresses proliferation and motility of hepatocellular carcinoma cells by activating steroid and xenobiotic receptor. Endocr J 56: 843-849, 2009.
70. Kodama S and Negishi M: Pregnane X receptor PXR activates the GADD45beta gene, eliciting the p38 MAPK signal and cell migration. J Biol Chem 286: 3570-3578, 2011.
71. van de Winkel A, Menke V, Capello A, et al: Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinoma. BMC Gastroenterol 11: 108, 2011.
72. van de Winkel A, van Zoest KP, van Dekken H, Moons LM, Kuipers EJ and van der Laan LJ: Differential expression of the nuclear receptors farnesoid X receptor (FXR) and pregnane X receptor (PXR) for grading dysplasia in patients with Barrett's oesophagus. Histopathology 58: 246-253, 2011.
73. Kawai M, Chen J, Cheung CY and Chang TK: Transcript profiling of cytochrome P450 genes in HL-60 human leukemic cells: upregulation of CYP1B1 by all-trans-retinoic acid. Mol Cell Biochem 248: 57-65, 2003.
74. Wang T, Ma X, Krausz KW, Idle JR and Gonzalez FJ: Role of pregnane X receptor in control of all-trans retinoic acid (ATRA) metabolism and its potential contribution to ATRA resistance. J Pharmacol Exp Ther 324: 674-684, 2008.
75. Zucchini N, de Sousa G, Bailly-Maitre B, Gugenheim J, Bars R, Lemaire G and Rahmani R: Regulation of Bcl-2 and Bcl-xL anti-apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes. Biochim Biophys Acta 1745: 48-58, 2005.
76. Wang K, Damjanov I and Wan YJ: The protective role of pregnane X receptor in lipopolysaccharide/D-galactosamine-induced acute liver injury. Lab Invest 90: 257-265, 2010.
77. Ouyang N, Ke S, Eagleton N, Xie Y, Chen G, Laffins B, Yao H, Zhou B and Tian Y: Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cells. Br J Cancer 102: 1753-1761, 2010.
78. Verma S, Tabb MM and Blumberg B: Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells. BMC Cancer 9: 3, 2009.
79. Liu C, Li J, Wang L, Wu F, Huang L, Xu Y, Ye J, Xiao B, Meng F, Chen S and Yang M: Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling. BMC Complement Altern Med 12: 5, 2012.
80. Zimmermann K, Wittman MD, Saulnier MG, et al: SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors. Bioorg Med Chem Lett 20: 1744-1748, 2010.
81. Healan-Greenberg C, Waring JF, Kempf DJ, Blomme EA, Tirona RG and Kim RB: A human immunodeficiency virus protease inhibitor is a novel functional inhibitor of human pregnane X receptor. Drug Metab Dispos 36: 500-507, 2008.
82. Huang H, Wang H, Sinz M, et al: Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole. Oncogene 26: 258-268, 2007.
83. Zhou C, Poulton EJ, Grün F, Bammler TK, Blumberg B, Thummel KE and Eaton DL: The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor. Mol Pharmacol 71: 220-229, 2007.
84. Kliewer SA, Goodwin B and Willson TM: The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 23: 687-702, 2002.